- Malin Corporation Plc (0Y71) has reported that Mycovia Pharmaceuticals, in which company’s priority asset, Viamet Pharmaceuticals, has an economic interest, has entered into a strategic partnership with Gedeon Richter Plc.
- The partnership is for the commercialisation and production of its main antifungal drug VT-1161 in Europe, Russia, Latin America, Australia, and some other CIS countries.
- Earlier this year Mycovia had entered into a strategic partnership with Jiangsu Hengrui Medicine to develop and commercialise VT-1161 in China.
With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities.
Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?
Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.
We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.